Heart rate variability: Evaluating a potential biomarker of anxiety disorders
Psychophysiology · 2024-02 · 61 (2)
DOI: 10.1111/psyp.14481 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Psychophysiology, online erschienen am 21.11.2023. Verfasst von Julia Tomasi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Brain Science Department, Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and…. Hauptthemen laut MEDLINE: Anxiety Disorders, Anxiety. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Establishing quantifiable biological markers associated with anxiety will increase the objectivity of phenotyping and enhance genetic research of anxiety disorders. Heart rate variability (HRV) is a physiological measure reflecting the dynamic relationship between the sympathetic and parasympathetic nervous systems, and is a promising target for further investigation. This review summarizes evidence evaluating HRV as a potential physiological biomarker of anxiety disorders by highlighting literature related to anxiety and HRV combined with investigations of endophenotypes, neuroimaging, treatment response, and genetics. Deficient HRV shows promise as an endophenotype of pathological anxiety and may serve as a noninvasive index of prefrontal cortical control over the amygdala, and potentially aid with treatment outcome prediction. We propose that the genetics of HRV can be used to enhance the understanding of the genetics of pathological anxiety for etiological investigations and treatment prediction. Given the anxiety–HRV link, strategies are offered to advance genetic analytical approaches, including the use of polygenic methods, wearable devices, and pharmacogenetic study designs. Overall, HRV shows promising support as a physiological biomarker of pathological anxiety, potentially in a transdiagnostic manner, with the heart–brain entwinement providing a novel approach to advance anxiety treatment development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Brain Science Department, Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
ORCID-Profile: Julia Tomasi
Zitieren
APA
Tomasi, J., Zai, C. C., Pouget, J. G., Tiwari, A. K., & Kennedy, J. L. (2024). Heart rate variability: Evaluating a potential biomarker of anxiety disorders. Psychophysiology, 61(2). https://doi.org/10.1111/psyp.14481
Vancouver
Tomasi J, Zai CC, Pouget JG, Tiwari AK, Kennedy JL. Heart rate variability: Evaluating a potential biomarker of anxiety disorders. Psychophysiology. 2024;61(2). doi:10.1111/psyp.14481
BibTeX
@article{Tomasi2024,
author = {Tomasi, Julia and Zai, Clement C and Pouget, Jennie G and Tiwari, Arun K and Kennedy, James L},
title = {Heart rate variability: Evaluating a potential biomarker of anxiety disorders},
journal = {Psychophysiology},
year = {2024},
volume = {61},
number = {2},
doi = {10.1111/psyp.14481}
}
EUVIMED